Osmolytes dynamically regulate mutant Huntingtin aggregation and CREB function in Huntington's disease cell models

被引:13
|
作者
Aravindan, Shreyaas [1 ]
Chen, Samantha [1 ]
Choudhry, Hannaan [1 ]
Molfetta, Celine [1 ]
Chen, Kuang Yu [2 ]
Liu, Alice Y. C. [1 ]
机构
[1] Rutgers State Univ, Dept Cell Biol & Neurosci, Nelson Biol Lab, 604 Allison Rd, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Dept Chem & Chem Biol, Nelson Biol Lab, 604 Allison Rd, Piscataway, NJ 08854 USA
关键词
INTRINSICALLY DISORDERED PROTEINS; NEURODEGENERATIVE DISEASES; CHEMICAL CHAPERONES; ORGANIC OSMOLYTES; GENE-EXPRESSION; HSP90; CLEARANCE; MUTATIONS; STABILITY; MECHANISM;
D O I
10.1038/s41598-020-72613-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Osmolytes are organic solutes that change the protein folding landscape shifting the equilibrium towards the folded state. Herein, we use osmolytes to probe the structuring and aggregation of the intrinsically disordered mutant Huntingtin (mHtt) vis-a-vis the pathogenicity of mHtt on transcription factor function and cell survival. Using an inducible PC12 cell model of Huntington's disease (HD), we show that stabilizing polyol osmolytes drive the aggregation of Htt103Q(Exon1)-EGFP from a diffuse ensemble into inclusion bodies (IBs), whereas the destabilizing osmolyte urea does not. This effect of stabilizing osmolytes is innate, generic, countered by urea, and unaffected by HSP70 and HSC70 knockdown. A qualitatively similar result of osmolyte-induced mHtt IB formation is observed in a conditionally immortalized striatal neuron model of HD, and IB formation correlates with improved survival under stress. Increased expression of diffuse mHtt sequesters the CREB transcription factor to repress CREB-reporter gene activity. This repression is mitigated either by stabilizing osmolytes, which deplete diffuse mHtt or by urea, which negates protein-protein interaction. Our results show that stabilizing polyol osmolytes promote mHtt aggregation, alleviate CREB dysfunction, and promote survival under stress to support the hypothesis that lower molecular weight entities of disease protein are relevant pathogenic species in neurodegeneration.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Normal huntingtin function: An alternative approach to Huntington's disease
    Cattaneo, E
    Zuccato, C
    Tartari, M
    NATURE REVIEWS NEUROSCIENCE, 2005, 6 (12) : 919 - 930
  • [32] Normal huntingtin function: an alternative approach to Huntington's disease
    Elena Cattaneo
    Chiara Zuccato
    Marzia Tartari
    Nature Reviews Neuroscience, 2005, 6 : 919 - 930
  • [33] Deciphering the Roles of Trehalose and Hsp104 in the Inhibition of Aggregation of Mutant Huntingtin in a Yeast Model of Huntington's Disease
    Chaudhary, Rajeev Kumar
    Kardani, Jay
    Singh, Kuljit
    Banerjee, Ruchira
    Roy, Ipsita
    NEUROMOLECULAR MEDICINE, 2014, 16 (02) : 280 - 291
  • [34] Deciphering the Roles of Trehalose and Hsp104 in the Inhibition of Aggregation of Mutant Huntingtin in a Yeast Model of Huntington’s Disease
    Rajeev Kumar Chaudhary
    Jay Kardani
    Kuljit Singh
    Ruchira Banerjee
    Ipsita Roy
    NeuroMolecular Medicine, 2014, 16 : 280 - 291
  • [35] Compounds blocking mutant huntingtin toxicity identified using a Huntington's disease neuronal cell model
    Wang, WF
    Duan, WZ
    Igarashi, S
    Morita, H
    Nakamura, M
    Ross, CA
    NEUROBIOLOGY OF DISEASE, 2005, 20 (02) : 500 - 508
  • [36] Transglutaminase 6 Is Colocalized and Interacts with Mutant Huntingtin in Huntington Disease Rodent Animal Models
    Schulze-Krebs, Anja
    Canneva, Fabio
    Stemick, Judith
    Plank, Anne-Christine
    Harrer, Julia
    Bates, Gillian P.
    Aeschlimann, Daniel
    Steffan, Joan S.
    von Hoersten, Stephan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [37] Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease
    Ehrnhoefer, Dagmar E.
    Martin, Dale D. O.
    Schmidt, Mandi E.
    Qiu, Xiaofan
    Ladha, Safia
    Caron, Nicholas S.
    Skotte, Niels H.
    Nguyen, Yen T. N.
    Vaid, Kuljeet
    Southwell, Amber L.
    Engemann, Sabine
    Franciosi, Sonia
    Hayden, Michael R.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2018, 6 : 16
  • [38] Allele-Specific Silencing of Mutant Huntingtin for Huntington's Disease Therapy
    Mas-Monteys, Alex
    Harper, Scott Q.
    Gilmore, Brian L.
    Staber, Patrick D.
    Schaffer, Chris
    Polisky, Barry
    Vargeese, Chandra
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2006, 13 : S274 - S275
  • [39] VALIDATION OF SUPPRESSORS OF MUTANT HUNTINGTIN TOXICITY IN A FLY MODEL OF HUNTINGTON'S DISEASE
    Casu, M.
    Campesan, S.
    Clapp, J.
    Kyriacou, C. P.
    Giorgini, F.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A11 - A11
  • [40] Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression
    Weiss, Andreas
    Traeger, Ulrike
    Wild, Edward J.
    Grueninger, Stephan
    Farmer, Ruth
    Landles, Christian
    Scahil, Rachael I.
    Lahiri, Nayana
    Haider, Salman
    Macdonald, Douglas
    Frost, Chris
    Bates, Gillian P.
    Bilbe, Graeme
    Kuhn, Rainer
    Andre, Ralph
    Tabrizi, Sarah J.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (10): : 3731 - 3736